Literature DB >> 24509126

Evolution of therapy inertia in primary care setting in Spain during 2002-2010.

Carlos Escobar1, Vivencio Barrios, F Javier Alonso-Moreno, Miguel Angel Prieto, Francisco Valls, Alberto Calderon, Jose Luis Llisterri.   

Abstract

OBJECTIVE: To determine the therapeutic behavior of primary care physicians in uncontrolled hypertensive patients in Spain during the last decade.
METHODS: Data were taken from three cross-sectional surveys aimed to determine the blood pressure (BP) control rates in treated hypertensive patients followed in a setting of primary care in Spain during 2002, 2006, and 2010, respectively. Adequate BP control was globally defined as BP lower than 140/90 mmHg for the hypertensive population in the three studies. In patients with diabetes, chronic kidney disease, or cardiovascular disease, BP control was established as lower than 130/85 mmHg in PRESión arterial en la población Española en los Centros de Atención Primaria (PRESCAP) 2002 and lower than 130/80 mmHg in PRESCAP 2006 and 2010.
RESULTS: A total of 12, 754, 10, 520, and 12, 961 patients were included in PRESCAP 2002, 2006, and 2010 studies. Of them, 36.1, 41.4, and 46.3%, respectively, achieved BP targets. In those patients with uncontrolled BP, physicians modified the treatment in 18.3, 30.4, and 41.4% of the cases, respectively (P = 0.0001). The most frequent action taken was the change to another drug in PRESCAP 2002 (47.0%), and the addition of other antihypertensive agent in PRESCAP 2006 and 2010 (46.3 and 55.6%, respectively). Predictors of therapeutic inertia were the physicians' perception of BP control, being on treatment with combined therapy, and the absence of risk factors or cardiovascular disease.
CONCLUSION: Although therapeutic inertia has decreased in the last years in primary care setting in Spain, nowadays in nearly 60% of patients with uncontrolled BP, no therapeutic action is actually taken. Therefore, despite a significant improvement, therapeutic inertia still remains a relevant clinical problem in hypertension general practice.

Entities:  

Mesh:

Year:  2014        PMID: 24509126     DOI: 10.1097/HJH.0000000000000118

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Clinical Profile and Management of Patient Patients with Ischemic Heart Disease and/or Peripheral Artery Disease in Clinical Practice: The APALUSA Study.

Authors:  Vivencio Barrios; Carlos Escobar; Carmen Suarez; Xavier Garcia-Moll; Francisco Lozano
Journal:  J Clin Med       Date:  2022-06-20       Impact factor: 4.964

2.  Untreated, Uncontrolled, and Apparent Resistant Hypertension: Results of the German Health Examination Survey 2008-2011.

Authors:  Giselle Sarganas; Hannelore K Neuhauser
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-02       Impact factor: 3.738

3.  Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China.

Authors:  Ross D Feldman; Lisheng Liu; Zhaosu Wu; Yuqing Zhang; Xueqing Yu; Xin-Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-26       Impact factor: 3.738

4.  Hypertension Prevalence, Awareness, Treatment, and Control: Should 24-Hour Ambulatory Blood Pressure Monitoring be the Tool of Choice?

Authors:  Anne Marie O'Flynn; Ronan J Curtin; Ivan J Perry; Patricia M Kearney
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-26       Impact factor: 3.738

5.  Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

Authors:  Omar Al Dhabyi; George L Bakris
Journal:  J Am Heart Assoc       Date:  2017-11-18       Impact factor: 5.501

6.  Factors associated with intensification of antihypertensive drug therapy in patients with poorly controlled hypertension.

Authors:  Olga Siga; Barbara Wizner; Barbara Gryglewska; Jolanta Walczewska; Tomasz Grodzicki
Journal:  J Geriatr Cardiol       Date:  2019-01       Impact factor: 3.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.